Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Single well reservoir characterization apparatus and methods
Method for fabricating a nitrided silicon-oxide gate dielectric
Chemically resistant membranes, coatings and films and methods for their preparation
UV exposure method for reducing residue in de-taping process
Electrical terminal
Apparatus and method for weighing an item of mail during transport through a sorting installation and having an anti-vibration device
System and method for text input with a multi-touch screen
  Randomly Featured Patents
Beer clarification process by crossflow microfiltration
Thiazolo-rifamycin derivatives and a method for their preparation
Polymer mixtures with improved odor control
Discharge lamp unit
Method for preparation of metal organic acid chelates
Fishing lure
Coating composition having good corrosion and oxidation resistance
Apparatus for loading bulk materials from a storage bin into a truck
Folding mirror structure
System for active noise control with audio signal compensation